|
Tracing the pathways of neurofibromatosis
January 19, 2007Michael Stern's latest research into the formation of neurofibromatosis tumors reads something like a federal racketeering indictment, except that Stern's tracing proteins instead of laundered money, and he's looking not at offshore accounts but at biochemical paths of cause and effect.
The research, which appears in the Jan. 10 issue of the Journal of Neuroscience, seeks to find the biochemical pathway that's responsible for tumors in people with the genetic disorder neurofibromatosis. Stern built his case much like a prosecutor, compiling evidence from dozens of painstaking experiments on mutant fruit flies, each with a specific genetic flaw that testified to the power of one or more proteins involved.
Neurofibromatosis is characterized by the formation of tumors of peripheral nerve cells. Scientists know the disease is caused by defects in a gene called Nf1, but they have yet to find out precisely how the defective genes cause tumors to form.
"Our results suggest that having a defect in Nf1 begins a kind of biochemical domino effect that eventually leads to tumor growth," said Stern, professor of biochemistry and cell biology.
Stern's research group used fruit flies for several reasons: the insect's genome has been sequenced; it takes only two weeks to grow an new generation of fruit flies; and scientists know which fruit fly genes are analogous to the human genes associated with neurofibromatosis.
In preparing for its experiments, Stern's group knew that Nf1 encodes a protein called neurofibromin that inhibits the effect of a second protein called Ras, which is known to promote nerve cell growth. They also knew that a third protein called PI3K was recently reported to be hyperactivated in mice that had defective Nf1 genes, and they knew that PI3K requires the activity of a fourth protein called Akt, to carry out its tasks.
In their experiments, they created more than two dozen mutant strains of fruit flies, including varieties that were either missing the genes to make one of the four proteins or were encoded to overexpress, or make extra amounts of, one of the four. Some mutants were designed to carry more than one defective trait.
Nerves from each mutant strain were examined. By comparing the mutant strains - each with a specific defect or set of defects - they buillt a case that the absence of neurofibromin allows Ras, PI3K and Akt to work in concert to inhibit a regulatory group of proteins called 'forkhead box O,' or FOXO. FOXO proteins are key players in regulating the genes responsible for programmed cell death and DNA repair - two common culprits in cancer.
"Our results raise the possibility that neurofibroma formation in individuals with neurofibromatosis might result in part from a Ras-PI3K-Akt-dependent inhibition of FOXO," Stern said.
Stern said the project required an enormous amount of work in the lab, and it wouldn't have been possible without the dedication and motivation of research technician Willliam Lavery, the paper's first author.
"Will displayed terrific leadership on this project," Stern said.
Rice University
"Our results suggest that having a defect in Nf1 begins a kind of biochemical domino effect that eventually leads to tumor growth," said Stern, professor of biochemistry and cell biology.
Stern's research group used fruit flies for several reasons: the insect's genome has been sequenced; it takes only two weeks to grow an new generation of fruit flies; and scientists know which fruit fly genes are analogous to the human genes associated with neurofibromatosis.
In preparing for its experiments, Stern's group knew that Nf1 encodes a protein called neurofibromin that inhibits the effect of a second protein called Ras, which is known to promote nerve cell growth. They also knew that a third protein called PI3K was recently reported to be hyperactivated in mice that had defective Nf1 genes, and they knew that PI3K requires the activity of a fourth protein called Akt, to carry out its tasks.
In their experiments, they created more than two dozen mutant strains of fruit flies, including varieties that were either missing the genes to make one of the four proteins or were encoded to overexpress, or make extra amounts of, one of the four. Some mutants were designed to carry more than one defective trait.
Nerves from each mutant strain were examined. By comparing the mutant strains - each with a specific defect or set of defects - they buillt a case that the absence of neurofibromin allows Ras, PI3K and Akt to work in concert to inhibit a regulatory group of proteins called 'forkhead box O,' or FOXO. FOXO proteins are key players in regulating the genes responsible for programmed cell death and DNA repair - two common culprits in cancer.
"Our results raise the possibility that neurofibroma formation in individuals with neurofibromatosis might result in part from a Ras-PI3K-Akt-dependent inhibition of FOXO," Stern said.
Stern said the project required an enormous amount of work in the lab, and it wouldn't have been possible without the dedication and motivation of research technician Willliam Lavery, the paper's first author.
"Will displayed terrific leadership on this project," Stern said.
Rice University
Neurofibromatosis News and Current Neurofibromatosis Events RSSProtein key to neuro-regeneration
Researchers at the Peninsula Medical School in the South West of England, University College London, the San Raffaele Scientific Institute in Milan and Cancer Research UK, have for the first time identified a protein that is key to the regeneration of damage in the peripheral nervous system and which could with further research lead to understanding diseases of our peripheral nervous systems and provide clues to methods of repairing damage in the central nervous system.
Research to lead to brain tumor therapies
Unique human in vitro model (cell culture) research currently underway at the Peninsula Medical School in the South West of England is set to identify and develop therapies for the treatment of multiple tumours in the brain.
Mouse model tightly matches pediatric tumor syndrome, will speed drug hunt
Frustrated by the slow pace of new drug development for a condition that causes pediatric brain tumors, a neurologist at Washington University School of Medicine in St. Louis decided to try to fine-tune the animal models used to test new drugs.
Cancer gene drives pivotal decision in early brain development
A gene linked to pediatric brain tumors is an essential driver of early brain development, researchers at Washington University School of Medicine in St. Louis have found.
Scientists find new agent to fight genetic disorders -- Zorro-Locked Nucleic Acid
A study to appear in the June 2007 issue of The FASEB Journal describes a new agent, called "Zorro-LNA," which has the potential to stop genetic disorders in their tracks.
For kids with high blood pressure, surgery can help when medicines fail
High blood pressure may seem like something that only adults get, after years of smoking, overeating and little exercise. But children can develop it too - and just as in adults, uncontrolled high blood pressure can pose serious risks to children's hearts, brains and lives.
Protein plays broader role than originally thought in neurofibromatosis
Neurofibromatosis type I is a common genetic disorder in which tumors grow along certain types of nerves and can also affect other tissues such as bone, heart, and skin.
Mouse to man: The story of chromosomes
The complete sequencing of human chromosome 17 and mouse chromosome 11 offers unique insights into the evolution of the genome of higher mammals.
A commonly prescribed drug reverses learning and attention deficits in a mouse model of the genetic disorder Neurofibromatosis type I
This week, researchers report evidence that a statin drug already shown to be safe for use in humans has proven effective at correcting cell-cell communication and curing learning disfunction in a mouse model of Neurofibromatosis type I, a human genetic disorder that causes learning disabilities in millions of people worldwide.
UCSF surgeon develops new spinal surgery technique
Called a lateral paramedian transpedicular approach, the technique uses advances in spinal instrumentation and reconstructive strategies to provide a direct approach to the removal of cervical spinal tumors with minimal, or no, neural manipulation.
More Neurofibromatosis News Articles
| © 2008 BrightSurf.com |